Eisai Seeks Accelerated Approval for Alzheimer’s Drug Lecanemab
Eisai’s investigational Alzheimer’s drug lecanemab appeared to erase amyloid plaques in 4/5 of trial participants and slow cognitive decline for people with early-stage Alzheimer’s…
Eisai’s investigational Alzheimer’s drug lecanemab appeared to erase amyloid plaques in 4/5 of trial participants and slow cognitive decline for people with early-stage Alzheimer’s…
In a new mouse study, Salk researchers found a drug, CMS121, that appears to treat neurodegeneration in mice. Researchers at the Salk Institute for…
More researchers are paying attention to the therapeutic benefits of psychedelics when it comes to treating mental illnesses like depression and addiction — and…
In a new study, scientists have tested an experimental drug in mice that may hold promise for future Alzheimer’s treatments. The drug involves a…
SAN DIEGO — A highly anticipated Alzheimer’s conference opened here last night with reports about a powerful new drug for treating dementia-related delusions. ACADIA…